On September 6, Brian King, the relatively new director of the Food and Drug Administration’s Center for Tobacco Products (CTP), would not say in an interview with Politico whether the agency was willing to take unauthorized vaping products off the market.
It was the first time that King had granted a media interview since beginning the role in early July.
Though everybody was eager to hear what he’d divulge, they all likely ended up disappointed. He said that he was “committing to explore all viable pathways that are legally and scientifically defensible,” adding that “nothing is off the table.” He did not acknowledge anything about the commission of external experts looking into CTP procedures. And he offered no specifics about any upcoming FDA enforcement, much to the chagrin of public health groups like the Michael Bloomberg-funded Campaign for Tobacco-Free Kids (CTFK) and legislators like Senator Dick Durbin.
It turns out, though, the agency had already started to take action.
Alex Norcia – Filter – 2022-09-13.